Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study - PubMed (original) (raw)
Multicenter Study
. 2005 Aug 17;97(16):1204-10.
doi: 10.1093/jnci/dji240.
Affiliations
- PMID: 16106025
- DOI: 10.1093/jnci/dji240
Multicenter Study
Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study
Anthony J Swerdlow et al. J Natl Cancer Inst. 2005.
Abstract
Background: Men with Klinefelter syndrome have one or more extra X chromosomes and have endocrine abnormalities. Case reports have led to suggestions that men with Klinefelter syndrome have elevated risks of several cancers, but published cohort studies have been relatively small. We conducted a nationwide cohort study to examine these risks.
Methods: We followed a cohort of 3518 men who had been cytogenetically diagnosed with Klinefelter syndrome in Britain from 1959 through 2002 and compared their cancer incidence and mortality with that of men in the national population. All statistical tests were two-sided.
Results: The standardized mortality ratio (SMR) for all cancers was 1.2 (95% confidence interval [CI] = 1.0 to 1.4). Compared with the general population, men with Klinefelter syndrome had higher mortality from lung cancer (SMR = 1.5, 95% CI = 1.0 to 2.0), breast cancer (SMR = 57.8, 95% CI = 18.8 to 135.0), and non-Hodgkin lymphoma (SMR = 3.5, 95% CI = 1.6 to 6.6) and lower mortality from prostate cancer (SMR = 0, 95% CI = 0 to 0.7). The standardized mortality ratios were particularly high for breast cancer among men with 47,XXY mosaicism (SMR = 222.8, 95% CI = 45.9 to 651.0) and for non-Hodgkin lymphoma among men with a 48,XXYY constitution (SMR = 36.7, 95% CI = 4.4 to 132.5). The cancer incidence data corroborated these associations.
Conclusions: These results support a hormonal etiology for breast cancer in men and for prostate cancer and suggest that men with Klinefelter syndrome may be at substantially elevated risks for non-Hodgkin lymphoma, breast cancer, and, perhaps, lung cancer.
Similar articles
- Mortality in patients with Klinefelter syndrome in Britain: a cohort study.
Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA; United Kingdom Clinical Cytogenetics Group. Swerdlow AJ, et al. J Clin Endocrinol Metab. 2005 Dec;90(12):6516-22. doi: 10.1210/jc.2005-1077. Epub 2005 Oct 4. J Clin Endocrinol Metab. 2005. PMID: 16204366 - Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort. Clifford GM, et al. J Natl Cancer Inst. 2005 Mar 16;97(6):425-32. doi: 10.1093/jnci/dji072. J Natl Cancer Inst. 2005. PMID: 15770006 - Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M, Chen BE, Jaffe ES, Travis LB. Hisada M, et al. J Natl Cancer Inst. 2007 Feb 7;99(3):215-22. doi: 10.1093/jnci/djk030. J Natl Cancer Inst. 2007. PMID: 17284716 - Morbidity and mortality in Klinefelter syndrome (47,XXY).
Bojesen A, Gravholt CH. Bojesen A, et al. Acta Paediatr. 2011 Jun;100(6):807-13. doi: 10.1111/j.1651-2227.2011.02274.x. Epub 2011 Apr 6. Acta Paediatr. 2011. PMID: 21414026 Review. - Klinefelter syndrome and cancer: from childhood to adulthood.
De Sanctis V, Fiscina B, Soliman A, Giovannini M, Yassin M. De Sanctis V, et al. Pediatr Endocrinol Rev. 2013 Sep;11(1):44-50. Pediatr Endocrinol Rev. 2013. PMID: 24079078 Review.
Cited by
- Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated.
Nieschlag E. Nieschlag E. Dtsch Arztebl Int. 2013 May;110(20):347-53. doi: 10.3238/arztebl.2013.0347. Epub 2013 May 17. Dtsch Arztebl Int. 2013. PMID: 23825486 Free PMC article. Review. - Male reproductive cancers and infertility: a mutual relationship.
Tvrda E, Agarwal A, Alkuhaimi N. Tvrda E, et al. Int J Mol Sci. 2015 Mar 31;16(4):7230-60. doi: 10.3390/ijms16047230. Int J Mol Sci. 2015. PMID: 25837470 Free PMC article. Review. - Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.
Carey-Smith SL, Kotecha RS, Cheung LC, Malinge S. Carey-Smith SL, et al. Int J Mol Sci. 2024 Jun 21;25(13):6815. doi: 10.3390/ijms25136815. Int J Mol Sci. 2024. PMID: 38999925 Free PMC article. Review. - Testosterone replacement in prostate cancer survivors with testosterone deficiency: Study protocol of a randomized controlled trial.
Valderrábano RJ, Pencina K, Storer TW, Reid KF, Kibel AS, Burnett AL, Huang G, Dorff T, Privat F, Ghattas-Puylara C, Wilson L, Latham NK, Holmberg M, Bhasin S. Valderrábano RJ, et al. Andrology. 2023 Jan;11(1):93-102. doi: 10.1111/andr.13299. Epub 2022 Oct 13. Andrology. 2023. PMID: 36181480 Free PMC article. - Risk factors for male breast cancer.
Fentiman IS. Fentiman IS. Am J Transl Res. 2023 Dec 15;15(12):6918-6925. eCollection 2023. Am J Transl Res. 2023. PMID: 38186995 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical